{"id":"https://openalex.org/W4403773009","doi":"https://doi.org/10.22377/ajp.v18i3.5640","title":"Molecular Docking Studies of Substituted Aromatic N-(3-chloro-4-fluorophenyl)-1- phenylmethanimine Derivatives against Monoamine Oxidase-B as Potential Anti-parkinsonian Agents","display_name":"Molecular Docking Studies of Substituted Aromatic N-(3-chloro-4-fluorophenyl)-1- phenylmethanimine Derivatives against Monoamine Oxidase-B as Potential Anti-parkinsonian Agents","publication_year":2024,"publication_date":"2024-09-01","ids":{"openalex":"https://openalex.org/W4403773009","doi":"https://doi.org/10.22377/ajp.v18i3.5640"},"language":"en","primary_location":{"id":"doi:10.22377/ajp.v18i3.5640","doi":"https://doi.org/10.22377/ajp.v18i3.5640","is_oa":true,"landing_page_url":"https://doi.org/10.22377/ajp.v18i3.5640","pdf_url":"http://www.asiapharmaceutics.info/index.php/ajp/article/download/5640/1679","source":{"id":"https://openalex.org/S66408587","display_name":"Asian Journal of Pharmaceutics","issn_l":"0973-8398","issn":["0973-8398","1998-409X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.asiapharmaceutics.info/index.php/ajp/article/download/5640/1679","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019638805","display_name":"Vijaya Kishore Kanakaraju","orcid":"https://orcid.org/0000-0003-4189-324X","observed_orcids":["https://orcid.org/0000-0003-4189-324X"]},"institutions":[{"id":"https://openalex.org/I177001074","display_name":"Acharya Nagarjuna University","ror":"https://ror.org/02mfapa96","country_code":"IN","type":"education","lineage":["https://openalex.org/I177001074"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Vijaya Kishore Kanakaraju","raw_affiliation_strings":["Department of Pharmaceutical Chemistry , College of Pharmaceutical Sciences , Acharya Nagarjuna University , Guntur , Andhra Pradesh , India,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry , College of Pharmaceutical Sciences , Acharya Nagarjuna University , Guntur , Andhra Pradesh , India,","institution_ids":["https://openalex.org/I177001074"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019638805"],"corresponding_institution_ids":["https://openalex.org/I177001074"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"03","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.07769999653100967,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mao-b-inhibitors","display_name":"monoamine oxidase B inhibitors","score":0.8339999914169312},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":0.9160000085830688},{"id":"https://openalex.org/keywords/rasagiline","display_name":"rasagiline","score":0.9959999918937683},{"id":"https://openalex.org/keywords/safinamide","display_name":"safinamide","score":0.9599999785423279},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.8230788707733154},{"id":"https://openalex.org/C39398028","wikidata":"https://www.wikidata.org/wiki/Q18028862","display_name":"Monoamine oxidase B","level":4,"score":0.6491549611091614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.62009197473526},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.554995059967041},{"id":"https://openalex.org/C114461151","wikidata":"https://www.wikidata.org/wiki/Q14888415","display_name":"Monoamine oxidase A","level":4,"score":0.4711317718029022},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4177040457725525},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.406754732131958},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23961806297302246},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.22264915704727173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18494859337806702},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22377/ajp.v18i3.5640","doi":"https://doi.org/10.22377/ajp.v18i3.5640","is_oa":true,"landing_page_url":"https://doi.org/10.22377/ajp.v18i3.5640","pdf_url":"http://www.asiapharmaceutics.info/index.php/ajp/article/download/5640/1679","source":{"id":"https://openalex.org/S66408587","display_name":"Asian Journal of Pharmaceutics","issn_l":"0973-8398","issn":["0973-8398","1998-409X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22377/ajp.v18i3.5640","doi":"https://doi.org/10.22377/ajp.v18i3.5640","is_oa":true,"landing_page_url":"https://doi.org/10.22377/ajp.v18i3.5640","pdf_url":"http://www.asiapharmaceutics.info/index.php/ajp/article/download/5640/1679","source":{"id":"https://openalex.org/S66408587","display_name":"Asian Journal of Pharmaceutics","issn_l":"0973-8398","issn":["0973-8398","1998-409X"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403773009.pdf","grobid_xml":"https://content.openalex.org/works/W4403773009.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220826070","https://openalex.org/W4405794745","https://openalex.org/W3117634363","https://openalex.org/W2792017095","https://openalex.org/W3214820637","https://openalex.org/W2171070555","https://openalex.org/W7210290149","https://openalex.org/W4403777176","https://openalex.org/W2620779400","https://openalex.org/W7119494793"],"abstract_inverted_index":{"Introduction:":[0],"In":[1],"recent":[2],"times,":[3],"Parkinson\u2019s":[4,217],"disease":[5],"has":[6],"been":[7,39],"considered":[8,212],"a":[9,30,196],"major":[10],"problem":[11],"in":[12],"most":[13],"of":[14,32,76,120,134,190,216],"the":[15,44,57,74,79,121,135,145,178,201,214],"men":[16],"than":[17,204],"women.":[18],"The":[19,132],"monoamine":[20],"oxidase-B":[21],"(MAO-B)":[22],"inhibitors":[23,62,181],"show":[24],"anti-Parkinsonian":[25],"activity.":[26],"This":[27],"study":[28],"describes":[29],"range":[31],"substituted":[33,191],"aromatic":[34,192],"N-(3-chloro-4-fluorophenyl)-1-phenylmethanimine":[35],"derivatives":[36],"that":[37,208],"have":[38,126,137,172],"designed":[40],"and":[41,59,67,70,83,87,106,117,157,165,182],"docked":[42,107],"against":[43],"MAO-B":[45,61,128,147,180,202],"enzyme":[46,129,203],"to":[47,91,101,125,171,177],"evaluate":[48],"their":[49],"potential":[50],"anti-Parkinson\u2019s":[51],"agents.":[52],"Comparison":[53],"was":[54,99],"made":[55],"between":[56],"ligands":[58,80,136],"common":[60],"such":[63,149],"as":[64,150],"selegiline,":[65],"rasagiline,":[66],"safinamide.":[68],"Materials":[69],"Methods:":[71],"First,":[72],"with":[73,144],"help":[75],"Chemsketch":[77],"software,":[78],"were":[81,89,109,123,169,184],"drawn":[82],"saved":[84],"in.mol":[85],"format,":[86],"they":[88,209],"converted":[90],".pdb":[92],"format":[93],"using":[94],"Avogadro":[95],"software.":[96],"iGEMDOCK":[97],"software":[98],"used":[100],"perform":[102],"molecular":[103],"docking":[104],"studies":[105],"compounds":[108],"visualized":[110],"through":[111],"BIOVIA":[112],"Discovery":[113],"Studio":[114],"Visualizer.":[115],"Results":[116],"Discussion:":[118],"Most":[119],"substances":[122],"found":[124,170],"enhanced":[127],"binding":[130,140,174,198],"affinities.":[131],"majority":[133],"demonstrated":[138],"greater":[139],"energies":[141,175],"when":[142],"compared":[143,176],"standard":[146,179,205],"inhibitors,":[148,206],"safinamide":[151],"(\u2212102.64":[152],"K.cal/mol),":[153,156],"selegiline":[154],"(\u221274.38":[155],"rasagiline":[158],"(\u221272.76":[159],"K.cal/mol).":[160],"Compounds":[161],"C23":[162],"(\u2212120.20":[163],"K.cal/mol)":[164,168],"C33":[166],"(\u2212116.97":[167],"superior":[173],"so":[183],"chosen":[185],"for":[186,213],"visualization.":[187],"Conclusion:":[188],"Derivatives":[189],"N-(3-chloro-4-fluorophenyl)-1-":[193],"phenylmethanimine":[194],"showed":[195],"higher":[197],"affinity":[199],"toward":[200],"suggesting":[207],"might":[210],"be":[211],"treatment":[215],"disorder.":[218]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-10-26T00:00:00"}